Summary
The results of antibody assays for viruses of the herpes group (HSV, EBV, VZV and CMV) and for hepatitis B virus (HBV) were retrospectively evaluated in 439 HIV-seropositive patients classified into different stages of HIV infection. The prevalence of specific IgG, IgM and IgA antibodies in these groups was compared with that of a control group of HIV-negative unselected hospital patients. Antibodies to herpes viruses and HBV were more prevalent amongst HIV-seropositives, especially LAS and AIDS patients than in controls. However, marked differences were found only with CMV-IgG and anti-HBc-IgG, both with a comparatively low prevalence in HIV-negative persons (64.5% and 23.2%). Significantly more seropositives were found among asymptomatic HIV carriers (83.3% and 50%) and still more in patients with full-blown AIDS (95.4% and 82.5%). The increased frequency of CMV and HBV antibodies, already seen in asymptomatic HIV patients reflects their higher risk for sexually transmitted infections. Moreover, IgA antibodies to CMV were detected in 25.4% of LAS and 37.3% of AIDS patients, respectively, but only in 7.6% of the controls. Elevated CMV-IgA titres were found exclusively in HIV-infected persons. The differences in the antibody patterns found in this cross-sectional study may reflect the progression of the HIV disease. However, prospective follow-up studies are required to assess the value of these markers as indicators of prognosis in HIV-infected subjects.
Zusammenfassung
Bei 439 HIV-positiven Patienten verschiedener Krankheitsstadien wurden retrospektiv die Ergebnisse der Antikörpertests gegen Viren der Herpesgruppe (HSV, EBV, VZV und CMV) und gegen Hepatitis-B-Virus (HBV) ausgewertet. Die Prävalenz spezifischer IgG-, IgM- und IgA-Antikörper wurde zwischen den verschiedenen Stadien der HIV-Infektion und mit einem Kontrollkollektiv HIV-negativer Krankhenhauspatienten verglichen. Die Durchseuchung mit Herpesviren und Hepatitis B war insgesamt bei HIV-positiven und insbesondere LAS-und AIDS-Patienten höher als im Kontrollkollektiv. Die größten Unterschiede zeigten sich für das CMV-IgG und das anti-HBc-IgG, beide mit einer vergleichsweise niedrigen Prävalenz bei HIV-negativen Personen (64,5% bzw. 23,2%). Der Anteil CMV und HBV-Seropositiver war deutlich höher in der Gruppe der asymptomatischen HIV-Träger (83,3% bzw. 50%) und noch mehr bei Patienten mit dem Vollbild AIDS (95,4% bzw. 82,5%). Die höhere Prävalenz von CMV- und HBV-Antikörpern bei asymptomatischen HIV- positiven Patienten entspricht ihrem erhöhten Risiko für sexuell übertragene Infektionen. Ferner wurde CMV-IgA bei 25,4% und 37,3% der LAS- bzw. AIDS-Patienten gegenüber nur 7,6% im Kontrollkollektiv nachgewiesen. Hohe CMV-IgA-Titer wurden ausschließlich bei HIV-infizierten Patienten gefunden. Der Vergleich der in dieser Querschnittsstudie gefundenen Antikörperprofile scheint die Progression der HIV-Krankheit widerzuspiegeln. Allerdings sind prospektive Verlaufsuntersuchungen erforderlich um den Wert dieser Marker als Prognosefaktoren sicher zu beurteilen.
Similar content being viewed by others
References
Cooper, E. H., Lacey, C. J. N. Laboratory indices of prognosis in HIV infection. Biomed. Pharmacother. 42 (1988) 539–546.
Enzensberger, R., Mergener, K., Selb, B., Doerr, H. W. Prognostischer Aussagewert HIV-serologischer Parameter. Lab. Med. 12 (1988) 249–253.
Helm, E. B., Brodt, R., Wegner, R., Staszweski, S., Joetten, L., Brill, H., Werner, A., Doerr, H. W., Bergmann, L., Behnken, L., Enzensberger, W., Schöfer, H., Mondorf, W., Stille, W. Spontanverlauf der HIV-Infektion. Eine Bilanz 5 Jahre nach den ersten AIDS-Erkrankungen in Frankfurt/Main. AIFO 10 (1987) 567–572.
Pedersen, C., Kolby, P., Gaub, J., Sindrup, J., Ullman, S., Gerstoft, J.: Disease progression in a cohort of 131 male homosexuals after 30 months of follow up. IV Int. Congr. AIDS 1988, Abstract No. 7770.
Rothenberg, R., Woelfel, M., Stoneburner, R., Milberg, J., Parker, R., Truman, B. Survival with the acquired immunodeficiency syndrome. Experience with 5,833 cases in New York City. N. Engl. J. Med. 317 (1987) 1297–1302.
Goedert, J. J., Biggar, R. J., Melbye, M., Mann, D. L., Wilson, S., Gail, M. H., Grossman, R. J., DiGioia, R. A., Sanchez, W. C., Weiss, S. H., Blattner, W. A. The effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with the human immunodeficiency virus. JAMA 257 (1987) 331–334.
Polk, B. F., Fox, R., Brookmeyer, R., Kanchanaraska, S., Kaslow, R., Visscher, B., Rinaldo, C., Phair, J. Predictors of the acquired immune deficiency syndrome developing in a cohort of seropositive homosexual men. N. Engl. J. Med. 316 (1987) 62–66.
Seligman, M., Pinching, A. J., Rosen, F. S. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Ann. Intern. Med. 107 (1987) 234–242.
Bentwich, Z., Burstein, R., Berner, Y., Gotlieb-Stematsky, T., Vonsover, A., Handzel, Z. Immune changes in male homosexuals — Predisposing factors for HIV seroconversion. Leukemia 2 (1988) 241S-247S.
Moss, A. R., Bacchetti, P., Osmond, D., Krampf, W., Chaisson, R. E., Stites, D., Wilber, J., Allain, J.-P., Carlson, J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow-up of the San Francisco General Hospital cohort. Br. Med. J. 296 (1988) 745–750.
Francioli, P., Clément, F., Glauser, M. P. β-2-Microglobulin: a sensitive non-specific marker of acquired immune deficiency syndrome. Eur. J. Clin. Microbiol. 3 (1984) 68–69.
Morfeldt-Månson, J., Julander, I., von Stedingk, L.-V., Wasserman, J., Nilsson, B. Elevated serum β-2-microglobulin — A prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy. Infection 16 (1988) 109–110.
Melmed, R. N., Taylor, J. M. G., Detels, R., Bozorgmehri, M., Fahey, J. L. Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J. AIDS 2 (1989) 70–76.
Goudsmit, J., Lange, J. M. A., Paul, D. A., Dawson, G. J. Antigenemia and antibody titres to core and envelope antigens in AIDS, AIDS- related complex and subclinical human immunodeficiency virus infection. J. Infect. Dis. 155 (1987) 558–560.
Hehlmann, R., Fischer, A., Matuschke, A., Mellert, W., Frösner, G. G., Goebel, F.-D., Erfle, V. Development of HIV markers during the later stages of HIV infections. AIFO 8 (1987) 441–447.
Weber, J. N., Weiss, R. A., Roberts, C., Weller, I. V. D., Tedder, R. S., Clapham, P. R., Parker, D., Duncan, J., Carne, C., Pinching, A. J., Cheingsong-Popov, R. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralizing sera and association of anti-gag antibody with prognosis. Lancet i (1987) 119–121.
de Wolf, F., Lange, J. M. A, Houweling, J. T. M., Mulder, J. W., Beemster, J., Schellekens, P. T., Coutinho, R. A., v. d. Noordaa, J., Goudsmit, J. Appearance of predictors of disease progression in relation to the development of AIDS. AIDS 3 (1989) 563–569.
Hofmann, B., Jakobsen, K. D., Skinhøj, P., Dickmeiss, E., Petersen, C. S., Fredericksen, B., Bygbjerg, I., Lindhardt, B. Ø., Gerstoft, J., Svejgaard, A.: A combination of immunological parameters and presence of HIV antigenemia is highly predictive for development of AIDS or HIV-related disease in subjects with antibodies to HIV investigated with a COX analysis. IV Intern. Conf. AIDS 1988, Abstract No. 7771.
Rinaldo, C. R., Jr., Kingsley, L. A., Lyter, D. W., Rabin, B. S., Atchison, R. W., Bodner, A. J., Weiss, S. H., Saxinger, W. C. Association of HTLV III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J. Infect. Dis. 154 (1986) 556–561.
Jackson, J. B., Erice, A., Englund, J. A., Edson, J. R., Balfour, H. H., Jr.: Prevalence of CMV antibody in haemophiliacs and homosexuals infected with HIV-1. IV Int. Congr. AIDS 1988, Abstract No. 7745.
Webster, A., Cook, D. G., Emery, V. C., Lee, C. A., Grundy, J. E., Kernoff, P. B. A., Griffiths, P. D. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet ii (1989) 63–65.
Pinching, A. J. Cytomegalovirus infection in the acquired immune deficiency syndrome. J. Antimicrob. Chemother. 23 (Suppl. E) (1989) 31–36.
Krueger, G. R. F. Infectious cofactors in HIV (HTLV III/LAV)-positive individuals and their implication for course and prognosis of acquired immunedeficiency, AIFO 12 (1986) 652–660.
Quinnan, G. V., Jr., Masur, H., Rook, A. H., Armstrong, G., Frederick, W. R., Epstein, J., Manischewitz, J. F., Macher, A. M., Jackson, L., Ames, J., Smith, H. A., Parker, M., Pearson, G. R., Parillo, J., Mitchell, C., Straus, S. E. Herpes-virus infections in the acquired immune deficiency syndrome. JAMA 252 (1984) 72–77.
CDC Classification system for human T lymphotropic virus type III/lymphadenopathy associated virus infection. MMWR 35 (1986) 334–339.
Matuschke, A., Heinrich, B., Hehlmann, R., Bogner, J., Füßl, H. S., Goebel, F.-D. Zusammenstellung gebräuchlicher Definitionen und Klassifikationssysteme bei HIV-Infektion. AIFO 11 (1989) 587–594.
Braun, W., Hehr, B., Rabenau, H., Doerr, H. W.: Serologische Diagnose der Zytomegalie bei immunsupprimierten Patienten. AIFO (1987) 634–638.
Sardov, I., Siqueira-Linhares, M., Chardonnet, Y., Levy, E., Aymard, M., Bosshard, S., Nord, E., Revillard, J. P. Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology 15 (1981) 228–234.
Brodie, H., Byrne, W. R., Drew, W. L., Graham, C., Kadakia, A., Williams, M. T.: CMV is not a factor in the progression of HIV infection. V. Int. Conf. AIDS 1989, WCP 80.
Ciobanu, N., Wiernick, P. H. Malignant lymphomas, AIDS and the pathogenic role of Epstein-Barr virus. Mt. Sinai J. Med. (NY) 53 (1986) 627–638.
Fiala, M., Cone, L. A., Chang, C. M., Mocarski, E. S. Cytomegalovirus viremia increases with progressive immunodeficiency in patients infected with HTLV III. AIDS Research 2 (1986) 175–181.
Kägi, M. K., Joller, H., Wunderli, W., Rüdlinger, R., Joller-Jemelka, H. I. Prävalenz von Cytomegalievirus, Hepatitis B-und HIV-1 Antikörpern bei gesunden Blutspendern, Spitalpatienten, Patienten mit Nierentransplantation, i.v.-Drogenabhängigen und Homosexuellen. Schweiz. Med. Wochenschr. 119 (1989) 217–222.
Nelson, J. A., Ghazal, P., Wiley, C. A. Role of opportunistic viral infections in AIDS. AIDS 4 (1990) 1–10.
Ter Meulen, J., Wittkowski, K. M., Kidenya, J. J., Pöllath, M., Dörries, R., Fleischer, K., Dietz, K., Ter Meulen, V. Evaluation of seroepidemiological associations between HIV infection, hepatitis B and other sexually transmitted diseases in African patients. Eur. J. Epidemiol. 15 (1989) 158–163.
Berry, N. J., McDonald Burns, D., Wannamethee, G., Grundy, J. E., Lui, S. F., Prentice, H. G., Griffith, P. D. Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases. J. Med. Virol. 24 (1988) 385–393.
Dannenmaier, B., Alle, W., Hoferer, E. W., Lorenz, D., Oertel, P.-J., Doerr, H. W. Incidences of antibodies to hepatitis B, herpes simplex and cytomegalovirus in prostitutes. Zbl. Bakt. Hyg. A 259 (1985) 257–283.
Gordin, F. M., Gibert, C., Hawley, H. P., Willoughby, A. Prevalence of human immunodeficiency virus and hepatitis B in unselected hospital admissions: Implications for mandatory testing and universal precautions. J. Infect. Dis. 161 (1990) 14–17.
Pass, R. F. Epidemiology and transmission of CMV. J. Infect. Dis. 152 (1985) 243–248.
Ben-Porath, E., Etzioni, A., Satinger, Y., Rimon, N., Pollak, S.: Can the infection rate of HBV serve as predictor of HIV infection? V Int. Conf. AIDS 1989, T.A.P. 81.
Author information
Authors and Affiliations
Additional information
Dedicated to Prof.G. Maas, Münster, for his sixty-fifth birthday.
Rights and permissions
About this article
Cite this article
Enzensberger, R., Braun, W., July, C. et al. Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection 19, 140–145 (1991). https://doi.org/10.1007/BF01643233
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01643233